These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 29107091)

  • 1. The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease.
    Zheng H; Zhou Q; Du Y; Li C; Xu P; Lin L; Xiao J; Gao H
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):263-273. PubMed ID: 29107091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length and micronuclei trajectories in APP/PS1 mouse model of Alzheimer's disease: Correlating with cognitive impairment and brain amyloidosis in a sexually dimorphic manner.
    Guo X; Li J; Qi Y; Chen J; Jiang M; Zhu L; Liu Z; Wang H; Wang G; Wang X
    Aging Cell; 2024 May; 23(5):e14121. PubMed ID: 38450924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-Specific Metabolomics Analysis Identifies the Liver as a Major Organ of Metabolic Disorders in Amyloid Precursor Protein/Presenilin 1 Mice of Alzheimer's Disease.
    Zheng H; Cai A; Shu Q; Niu Y; Xu P; Li C; Lin L; Gao H
    J Proteome Res; 2019 Mar; 18(3):1218-1227. PubMed ID: 30592618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
    Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
    Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
    Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
    Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
    Lok K; Zhao H; Shen H; Wang Z; Gao X; Zhao W; Yin M
    Neurosci Lett; 2013 Dec; 557 Pt B():84-9. PubMed ID: 24176881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of glucose in the brain of APP/PS1 transgenic mice at 10 months of age: a
    Zhou Q; Zheng H; Chen J; Li C; Du Y; Xia H; Gao H
    Metab Brain Dis; 2018 Oct; 33(5):1661-1668. PubMed ID: 29946959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.
    Wang Y; Zhou Z; Tan H; Zhu S; Wang Y; Sun Y; Li XM; Wang JF
    J Alzheimers Dis; 2017; 55(4):1683-1692. PubMed ID: 27911305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.
    Puig KL; Kulas JA; Franklin W; Rakoczy SG; Taglialatela G; Brown-Borg HM; Combs CK
    Neurobiol Aging; 2016 Apr; 40():22-40. PubMed ID: 26973101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-life environmental enrichment preserves short-term memory and may attenuate microglia in male APP/PS1 mice.
    Stuart KE; King AE; King NE; Collins JM; Vickers JC; Ziebell JM
    Neuroscience; 2019 Jun; 408():282-292. PubMed ID: 30999032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin Attenuates Oxidative Stress and Apoptosis in Brain Tissue of APP/PS1 Double Transgenic AD Mice by Regulating Keap1/Nrf2/HO-1 Pathway to Improve Cognitive Impairment.
    Cheng M; Yuan C; Ju Y; Liu Y; Shi B; Yang Y; Jin S; He X; Zhang L; Min D
    Behav Neurol; 2024; 2024():5698119. PubMed ID: 39233848
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer's disease.
    Wang D; Di X; Fu L; Li Y; Han X; Wu H; Cai L; Meng X; Jiang C; Kong W; Su W
    Neuroreport; 2016 Oct; 27(15):1114-9. PubMed ID: 27541273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Naert G; Rivest S
    J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reproduction,genotype identification and evaluation of APP/PS1 transgenic mice].
    Tan L; Li HQ; Li YB; Liu W; Pang W; Jiang YG
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Feb; 34(2):111-114. PubMed ID: 29926672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy.
    Deng M; Huang L; Ning B; Wang N; Zhang Q; Zhu C; Fang Y
    Brain Res; 2016 Dec; 1652():188-194. PubMed ID: 27737765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
    Chang KL; Wong LR; Pee HN; Yang S; Ho PC
    Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.